Neutrophil-To-Lymphocyte Ratio (Nlr) As A Potential Prognostic Marker In Patients With Hormone Receptor-Positive/Her2-Negative Advanced-Stage Breast Cancer Treated With Cdk4/6 Inhibitors: A Focus On Ribociclib
Ribociclib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Neutrophil-To-Lymphocyte Ratio (Nlr) As A Potential Prognostic Marker In Patients With Hormone Receptor-Positive/Her2-Negative Advanced-Stage Breast Cancer Treated With Cdk4/6 Inhibitors: A Focus On Ribociclib ### Output: Ribociclib